About Index Trending news
Analyze
Pricing
Oragenics

Oragenics

Work at Oragenics? Add yourself to this profile

Oragenics

We are a biopharmaceutical company focused primarily on oral probiotics products and novel antibiotics for humans and companion pets.
Edit Profile
More info

Elsewhere

Companies in the same industry

myMatrixx myMatrixx 3Scan 3Scan 3P Biopharmaceuticals 3P Biopharmaceuticals Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc. Mitochon Pharmaceuticals Mitochon Pharmaceuticals Arrivo BioVentures LLC Arrivo BioVentures LLC Nevakar Nevakar Viventia Bio Inc. Viventia Bio Inc. Genialis Genialis Dave Greenwald, Ph.D Dave Greenwald, Ph.D

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Post-IPO equity
$3,000,000
Venture capital
$4,670,000
Employees

Unknown size

Locations
HQ
United States
Headquarters
$3,000,000 Post-IPO equity
businesswire

Oragenics Announces Completion of Second Closing of $3.0 Million Preferred Stock Private Placement

Oragenics
Oragenics